Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels.
Jasmijn A M SleutjesJeanine E Roeters van LennepEric BoersmaLuis A MenchenMatthias LaudesKlaudia FarkasTamás MolnárNicholas Alexander KennedyMarieke J PierikChristien J van der WoudeAnnemarie C de VriesPublished in: Alimentary pharmacology & therapeutics (2021)
Increase in total cholesterol levels was strongest for corticosteroids followed by tofacitinib but was not observed for anti-TNFα agents. Whether total cholesterol change associated with IBD treatment has an effect on cardiovascular risk requires further study.